3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
70
Rectal Neoplasms
28
Colonic Neoplasms
28
Carcinoma, Hepatocellular
26
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
7
Cholangiocarcinoma
6
Adenocarcinoma Of Esophagus
6
Esophageal Neoplasms
5
Recurrence
4
Liver Neoplasms
4
Biliary Tract Neoplasms
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Gastrointestinal Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Adenocarcinoma
2
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma
1
Operable T2-3N+M0 Rectal Cancer (Stage III)
1
Oligometastatic Gastric Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neuropathy, Painful
1
Neuralgia
1
Interventions
Oxaliplatin
3
Irinotecan
3
Fluorouracil
3
Capecitabine
3
Bevacizumab
3
Leucovorin
2
Colonoscopy
2
Bisacodyl
2
Aspirin
2
lutetium Lu 177 dotatate
1
guadecitabine
1
copper dotatate CU-64
1
camrelizumab
1
apatinib
1
aldesleukin
1
XELOX
1
Ursodeoxycholic Acid
1
Trastuzumab
1
Suction
1
Simvastatin
1
Radiotherapy
1
Polyethylene Glycols
1
Oviposition
1
Lutetium-177
1
Lutetium
1
Ileostomy
1
Folfox protocol
1
Drainage
1
Cyclophosphamide
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Intestinal Neoplasms
×
Folfox protocol
×
Clear all
NCT03280407
2017-09-28
NEOLAR
Zealand University Hospital
Phase 2
Unknown
124 enrolled